Literature DB >> 12615297

An overview on the use of a viral pathogen as a bioterrorism agent: why smallpox?

B W J Mahy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12615297     DOI： 10.1016/s0166-3542(02)00194-8

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  5 in total

1.  Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.

Authors:  Chad Myskiw; Yvon Deschambault; Kristel Jefferies; Runtao He; Jingxin Cao
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

Review 2.  Host-based antipoxvirus therapeutic strategies: turning the tables.

Authors:  Anthony S Fauci; Mark D Challberg
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system.

Authors:  James J McSharry; Mark R Deziel; Kris Zager; Qingmei Weng; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

Review 4.  Biowarfare and bioterrorism.

Authors:  Michael D Christian
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

Review 5.  Antivirals and antiviral strategies.

Authors:  Erik De Clercq
Journal:  Nat Rev Microbiol       Date:  2004-09       Impact factor: 60.633
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.